Claire Aldridge, PhD, Form Bio's visionary chief strategy officer, pioneers advanced pharmaceutical solutions to get lifesaving therapeutics to patients. She was recently selected as one of Forbes’ 10 Women Leading the Synthetic Biology Revolution redefining the future of the pharmaceutical industry. Her distinguished career includes biotech venture investing, entrepreneurship, and translating scientific discovery into practical solutions. Aldridge holds a BS in biomedical science from Texas A&M University and a PhD in immunology and genetics from Duke University.
Articles by Claire Aldridge, PhD
|3 min read
AI’s Impact on Drug Development: Opportunities for Pharmaceutical Leaders
Explore the transformative impact of artificial intelligence on drug development and its role in the future of pharmaceutical innovationPage 1 of 1
